keyword
https://read.qxmd.com/read/38645302/effectiveness-of-interpersonal-psychotherapy-in-comparison-to-other-psychological-and-pharmacological-interventions-for-reducing-depressive-symptoms-in-women-diagnosed-with-postpartum-depression-in-low-and-middle-income-countries-a-systematic-review
#1
REVIEW
Harmeet Kaur Kang, Bandana Bisht, Manmeet Kaur, Obrey Alexis, Aaron Worsley, Denny John
BACKGROUND: Postpartum depression (PPD) is a condition that can affect any woman regardless of ethnicity, age, party, marital status, income, and type of delivery. This condition is highly prevalent worldwide. PPD, if not treated timely, can affect the maternal-child bond and can have a detrimental impact on the future cognitive, emotional, and behavioral development of the child. Interpersonal psychotherapy (IPT) has been reported as an effective treatment of PPD in previous studies as this focuses on relationship and social support issues...
June 2024: Campbell Syst Rev
https://read.qxmd.com/read/38642503/conjugation-of-sulpiride-with-a-cell-penetrating-peptide-to-augment-the-antidepressant-efficacy-and-reduce-serum-prolactin-levels
#2
JOURNAL ARTICLE
Yuan Liang, Yu Yang, Ruiyan Huang, Jiangyue Ning, Xingyan Bao, Zelong Yan, Haotian Chen, Li Ding, Chang Shu
Depression ranks as the fourth most prevalent global disease, with suicide incidents occurring at a younger age. Sulpiride (SUL), an atypical antidepressant drug acting as a dopamine D2 receptor antagonist and possessing anti-inflammatory properties, exhibits limited ability to penetrate the blood brain barrier (BBB). This weak penetration hampers its inhibitory effect on prolactin release in the pituitary gland, consequently leading to hyperprolactinemia. In order to enhance the central nervous system efficacy of sulpiride and reduce serum prolactin levels, we covalently linked sulpiride to VPALR derived from the nuclear DNA repair protein ku70...
April 19, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38641892/study-on-exosomes-for-identifying-bipolar-disorder-in-early-stage-a-cross-sectional-and-validation-study-protocol
#3
JOURNAL ARTICLE
Yanqing Wu, Yuchao Li, Xuguang An, Jiangong Li, Chenghao Yang, Yi Wang
BACKGROUND: The difficulty is remained to accurately distinguish bipolar disorder (BD) from major depressive disorder (MDD) in early stage, with a delayed diagnosis for 5-10 years. BD patients are often treated with antidepressants systematically due to being diagnosed with MDD, affecting the disease course and clinical outcomes. The current study aims to explore the role of plasma exosomes as biomarker to distinguish BD from MDD in early stage. METHODS: Two stages are included...
April 2024: Brain and Behavior
https://read.qxmd.com/read/38641767/real-world-evidence-from-a-retrospective-study-on-suicide-during-depression-clinical-characteristics-treatment-patterns-and-disease-burden
#4
JOURNAL ARTICLE
Han Wang, Nan Lyu, Juan Huang, Bingbing Fu, Lili Shang, Fan Yang, Qian Zhao, Gang Wang
BACKGROUND: Suicide stands as both a primary symptom and the direst outcome of major depressive disorder (MDD). The scarcity of effective treatment strategies makes managing MDD patients with suicide especially challenging. Hence, it is crucial to investigate disease characteristics and efficacious therapeutic strategies for these patients, drawing insights from disease databases and real-world data. METHODS: In this retrospective study, MDD patients hospitalized between January 2013 and December 2020 were investigated using Electronic Health Records (EHR) data from Beijing Anding Hospital...
April 19, 2024: BMC Psychiatry
https://read.qxmd.com/read/38635747/risk-factors-of-reattempt-among-suicide-attempters-in-south-korea-a-nationwide-retrospective-cohort-study
#5
JOURNAL ARTICLE
Min Ji Kim, Jeong Hun Yang, Min Jung Koh, Youngdoe Kim, Bolam Lee, Yong Min Ahn
This study aimed to identify underlying demographic and clinical characteristics among individuals who had previously attempted suicide, utilizing the comprehensive Health Insurance Review and Assessment Service (HIRA) database. Data of patients aged 18 and above who had attempted suicide between January 1 and December 31, 2014, recorded in HIRA, were extracted. The index date was identified when a suicide attempt was made within the year 2014. The medical history of the three years before the index date and seven years of follow-up data after the index date were analyzed...
2024: PloS One
https://read.qxmd.com/read/38629111/disparities-in-the-prevalence-of-suicidal-ideation-according-to-oral-contraceptive-pill-use-among-us-women-a-cross-sectional-study
#6
JOURNAL ARTICLE
Julia Gawronska, Chao Cao, Ruixuan Wang, Dong Keon Yon, Masoud Rahmati, Matthew Jewiss, Lee Smith
BACKGROUND AND AIMS: The relationship between oral contraceptive pill (OCP) and suicidal ideation remains unclear. This study aims to estimate the prevalence of suicidal ideation among US women and evaluate their associates overall and according to OCP use status. METHODS: Data from the National Health and Nutrition Examination Survey (NHANES) 2005-2012 were used to calculate the prevalence and associates of suicidal ideation in women using OCP. Suicidal ideation was assessed using the Patient Health Questionnaire-9...
April 2024: Health Science Reports
https://read.qxmd.com/read/38628605/preventable-suicides-involving-medicines-a-systematic-case-series-of-coroners-reports-in-england-and-wales
#7
JOURNAL ARTICLE
G Anthony, J K Aronson, R Brittain, C Heneghan, G C Richards
BACKGROUND: In England and Wales coroners have a duty to write a report, called a Prevention of Future Deaths report or PFD, when they believe that actions should be taken to prevent future deaths. Coroners send PFDs to individuals and organisations who are required to respond within 56 days. Despite the increase in mental health concerns and growing use of medicines, deaths reported by coroners that have involved medicine-related suicides had not yet been explored. Therefore, this study aimed to systematically assess coroners' PFD reports involving suicides in which a medicine caused or contributed to the death to identify lessons for suicide prevention...
June 2024: Public health in practice
https://read.qxmd.com/read/38627605/a-scientometric-analysis-and-visualisation-of-elderly-suicide-research-from-1951-to-2022
#8
JOURNAL ARTICLE
Seher Palanbek Yavaş, Caner Baysan
BACKGROUND: There are still many gaps in both national and international literature on elderly suicide. This study aimed to identify the most influential journals in elderly suicide, the countries and authors that contribute the most to the field, and the trends in the field. MATERIAL AND METHODS: Studies published on elderly suicide between 1951 and 2022 were retrieved utilising the Web of Science Core Collection. Co-authorship analysis of countries and authors, as well as co-occurrence analysis of keywords, were conducted using VOSviewer 1...
April 16, 2024: Psychogeriatrics: the Official Journal of the Japanese Psychogeriatric Society
https://read.qxmd.com/read/38615365/quercetin-alleviates-chronic-unpredictable-mild-stress-induced-depression-like-behavior-by-inhibiting-nmdar1-with-%C3%AE-2%C3%AE-1-in-rats
#9
JOURNAL ARTICLE
Mingyan Wang, Xin Wei, Yugai Jia, Chaonan Wang, Xinliu Wang, Xin Zhang, Depei Li, Yuanyuan Wang, Yonggang Gao
BACKGROUND: Depression is a serious mental disorder and the most prevalent cause of disability and suicide worldwide. Chronic unpredictable mild stress (CUMS) can lead to a significant acceleration of depression development. Quercetin (Que) is a flavonoid compound with a wide range of pharmacological effects. Recent studies have shown that quercetin can improve CUMS-induced depression-like behavior, but the mechanism of its improvement is still unclear. α2δ-1 is a regulatory subunit of voltage-gated calcium channel, which can interact with N-methyl-D-aspartate receptor (NMDAR) to form a complex...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38587055/suicide-ideation-and-male-female-differences-in-major-depressive-disorder
#10
JOURNAL ARTICLE
Paolo Olgiati, Basilio Pecorino, Alessandro Serretti
OBJECTIVE: This study aimed to explore male-female differences in suicide ideation (SI) and suicide risk factors in major depressive disorder (MDD). METHODS: We analysed 482 adults (sample 1) and 438 elderly outpatients (sample 2) with MDD. Sample 1 was treated with different antidepressant combinations (escitalopram; bupropion plus escitalopram; venlafaxine plus mirtazapine) and assessed by means of the Concise Health Risk Tracking (SI), Quick Inventory of Depressive Symptomatology, Altman Mania Rating Scale and Psychiatric Diagnostic Screening Questionnaire...
April 8, 2024: International Journal of Psychiatry in Clinical Practice
https://read.qxmd.com/read/38585482/risk-factors-for-suicidal-attempts-in-a-sample-of-outpatients-with-treatment-resistant-depression-an-observational-study
#11
JOURNAL ARTICLE
Serena Chiara Civardi, Filippo Besana, Giovanni Carnevale Miacca, Filippo Mazzoni, Vincenzo Arienti, Pierluigi Politi, Natascia Brondino, Miriam Olivola
INTRODUCTION: Treatment-resistant depression (TRD) is commonly defined as the failure of at least two trials with antidepressant drugs, given at the right dose and for an appropriate duration. TRD is associated with increased mortality, compared to patients with a simple major depressive episode. This increased rate was mainly attributed to death from external causes, including suicide and accidents. The aim of our study is to identify socio-demographic and psychopathological variables associated with suicidal attempts in a sample of outpatients with TRD...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38582152/network-pharmacology-and-experimental-evidence-erk-creb-bdnf-signaling-pathway-is-involved-in-the-antidepressive-roles-of-kaiyu-zhishen-decoction
#12
JOURNAL ARTICLE
Ying Chen, Xiangxu Chen, Jialin Zhang, Xuejun Zhang, Dan Wang, Na Lu, Changsong Wang, Yingying Yue, Yonggui Yuan
ETHNOPHARMACOLOGICAL RELEVANCE: Major Depressive Disorder (MDD) emerges as a complex psychosomatic condition, notable for its considerable suicidality and mortality rates. Increasing evidence suggests the efficacy of Chinese herbal medicine in mitigating depression symptoms and offsetting the adverse effects associated with conventional Western therapeutics. Notably, clinical trials have revealed the adjunctive antidepressant potential of Kaiyu Zhishen Decoction (KZD) alongside Western medication...
April 4, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38575806/ketamine-s-mechanism-of-action-with-an-emphasis-on-neuroimmune-regulation-can-the-complement-system-complement-ketamine-s-antidepressant-effects
#13
REVIEW
Brandi Quintanilla, Carlos A Zarate, Anilkumar Pillai
Over 300 million people worldwide suffer from major depressive disorder (MDD). Unfortunately, only 30-40% of patients with MDD achieve complete remission after conventional monoamine antidepressant therapy. In recent years, ketamine has revolutionized the treatment of MDD, with its rapid antidepressant effects manifesting within a few hours as opposed to weeks with conventional antidepressants. Many research endeavors have sought to identify ketamine's mechanism of action in mood disorders; while many studies have focused on ketamine's role in glutamatergic modulation, several studies have implicated its role in regulating neuroinflammation...
April 4, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38574853/clinical-characteristics-and-treatment-exposure-of-patients-with-marked-treatment-resistant-unipolar-major-depressive-disorder-a-recover-trial-report
#14
JOURNAL ARTICLE
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Walter Duffy, Mary Stedman, João Quevedo, Rebecca M Allen, Patricio Riva-Posse, Matthew A Berger, Gustavo Alva, Mohd Azfar Malik, David L Dunner, Ivan Cichowicz, Heather Luing, John Zajecka, Ziad Nahas, Brian J Mickey, Anita S Kablinger, Christopher L Kriedt, Mark T Bunker, Ying-Chieh Lisa Lee, Olivia Shy, Shannon Majewski, Bryan Olin, Quyen Tran, A John Rush
BACKGROUND: RECOVER is a randomized sham-controlled trial of vagus nerve stimulation and the largest such trial conducted with a psychiatric neuromodulation intervention. OBJECTIVE: To describe pre-implantation baseline clinical characteristics and treatment history of patients with unipolar, major depressive disorder (MDD), overall and as a function of exposure to interventional psychiatric treatments (INTs), including electroconvulsive therapy, transcranial magnetic stimulation, and esketamine...
April 2, 2024: Brain Stimulation
https://read.qxmd.com/read/38573154/acute-dissociation-and-ketamine-s-antidepressant-and-anti-suicidal-ideation-effects-in-a-midazolam-controlled-trial
#15
JOURNAL ARTICLE
Sumra Sajid, Hanga C Galfalvy, John G Keilp, Ainsley K Burke, J John Mann, Michael F Grunebaum
OBJECTIVE: Explore relationships of acute dissociative effects of intravenous ketamine with change in depression and suicidal ideation and with plasma metabolite levels in a randomized, midazolam-controlled trial. METHOD: Data from a completed trial in suicidal, depressed participants (N=40) randomized to ketamine was used to examine relationships between ketamine treatment-emergent dissociative and psychotomimetic symptoms with pre/post-infusion changes in suicidal ideation and depression severity...
April 4, 2024: International Journal of Neuropsychopharmacology
https://read.qxmd.com/read/38568605/susceptibility-to-treatment-resistant-depression-within-families
#16
JOURNAL ARTICLE
Chih-Ming Cheng, Mu-Hong Chen, Shih-Jen Tsai, Wen-Han Chang, Chia-Fen Tsai, Wei-Chen Lin, Ya-Mei Bai, Tung-Ping Su, Tzeng-Ji Chen, Cheng-Ta Li
IMPORTANCE: Antidepressant responses and the phenotype of treatment-resistant depression (TRD) are believed to have a genetic basis. Genetic susceptibility between the TRD phenotype and other psychiatric disorders has also been established in previous genetic studies, but population-based cohort studies have not yet provided evidence to support these outcomes. OBJECTIVE: To estimate the TRD susceptibility and the susceptibility between TRD and other psychiatric disorders within families in a nationwide insurance cohort with extremely high coverage and comprehensive health care data...
April 3, 2024: JAMA Psychiatry
https://read.qxmd.com/read/38568139/prospective-acceptability-of-digital-therapy-for-major-depressive-disorder-in-france-multicentric-real-life-study
#17
JOURNAL ARTICLE
Odile Amiot, Anne Sauvaget, Isabelle Alamome, Samuel Bulteau, Thomas Charpeaud, Anne-Hélène Clair, Philippe Courtet, Dominique Drapier, Emmanuel Haffen, Eric Fakra, Gaudeau-Bosma Christian, Adeline Gourion-Gaillard, Stéphane Mouchabac, Fanny Pineau, Véronique Narboni, Anne Duburcq, Laurent Lecardeur
BACKGROUND: Major depressive disorder is one of the leading causes of disability worldwide. Recently, the WHO has highlighted the negative impact of recent crises (COVID-19 pandemic, war in Ukraine, economic crisis). Although most international guidelines recommend psychological and psychosocial interventions as a first-line treatment for mild to moderate depression, access remains limited in France due to limited availability of trained clinicians, high costs for patients in a context of non-reimbursement and fear of stigmatisation...
April 3, 2024: JMIR Formative Research
https://read.qxmd.com/read/38564099/risk-and-protective-factors-of-self-harm-and-suicidality-in-adolescents-an-umbrella-review-with-meta-analysis
#18
JOURNAL ARTICLE
Rebecca Richardson, Tanya Connell, Mandie Foster, Julie Blamires, Smita Keshoor, Chris Moir, Irene Suilan Zeng
Suicide remains the second most common cause of death in young people aged 10-24 years and is a growing concern globally. The literature reports a vast number of factors that can predispose an adolescent to suicidality at an individual, relational, community, or societal level. There is limited high-level research identifying and understanding these risk and protective factors of adolescent suicidality. The present study used an umbrella review and meta-analysis to synthesize evidence from the review literature in the past 20 years on risk and protective factors of self-harm and suicidality (behavior and ideation) in adolescents...
April 2, 2024: Journal of Youth and Adolescence
https://read.qxmd.com/read/38555993/plasma-complement-and-coagulation-proteins-as-prognostic-factors-of-negative-symptoms-an-analysis-of-the-napls-2-and-3-studies
#19
JOURNAL ARTICLE
Jonah F Byrne, Colm Healy, Melanie Föcking, Meike Heurich, Subash Raj Susai, David Mongan, Kieran Wynne, Eleftheria Kodosaki, Scott W Woods, Barbara A Cornblatt, William S Stone, Daniel H Mathalon, Carrie E Bearden, Kristin S Cadenhead, Jean Addington, Elaine F Walker, Tyrone D Cannon, Mary Cannon, Clark Jeffries, Diana Perkins, David R Cotter
INTRODUCTION: Negative symptoms impact the quality of life of individuals with psychosis and current treatment options for negative symptoms have limited effectiveness. Previous studies have demonstrated that complement and coagulation pathway protein levels are related to later psychotic experiences, psychotic disorder, and functioning. However, the prognostic relationship between complement and coagulation proteins and negative symptoms is poorly characterised. METHODS: In the North American Prodrome Longitudinal Studies 2 and 3, negative symptoms in 431 individuals at clinical high-risk for psychosis (mean age: 18...
March 29, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38552915/anxiety-symptoms-preceding-suicide-a-swedish-nationwide-record-review
#20
JOURNAL ARTICLE
Sabrina Doering, Sara Probert-Lindström, Anna Ehnvall, Stefan Wiktorsson, Nina Palmqvist Öberg, Erik Bergqvist, Anne Stefenson, Jesper Fransson, Åsa Westrin, Margda Waern
BACKGROUND: The literature on the relationship between anxiety and suicidal behaviors is limited and findings are mixed. This study sought to determine whether physicians noted anxiety symptoms and suicidality in their patients in the weeks and months before suicide. METHODS: Data were derived from a nationwide medical record review of confirmed suicides in Sweden in 2015. Individuals with at least one documented physician consultation in any health care setting during 12 months before suicide (N = 956) were included...
March 27, 2024: Journal of Affective Disorders
keyword
keyword
59303
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.